![Dialysis Percutaneous AVF (pAVF)](/_next/image?url=https%3A%2F%2Fcoatconnect-files.s3.amazonaws.com%2FDev%2FCover-fd6a1633-557e-4d8a-8950-bad145541f5f-0b9311d9-132b-4b35-9ae9-7ff888b0ea54-pexels-rodnae-productions-6129044_1920X1080.webp%3FAWSAccessKeyId%3DAKIAJTMHAFAXQLGGIHMA%26Expires%3D1804066285%26Signature%3DPAJ%252BBCeLoxcWoZd83Dmc8671Eek%253D&w=3840&q=75)
Dialysis Percutaneous AVF (pAVF)
Dialysis Percutaneous AVF (pAVF) is organized by University of Cincinnati Continuing Medical Education (UC-CME).
Release: February 1, 2022
Expires: January 31, 2025
Overview:
In June 2018, the U.S. FDA permitted the marketing of two catheter-based devices designed to create dialysis AVF via percutaneous catheter-guided techniques. Devices function to avoid aspects of surgical complications: poor incisional site healing, Vessel clamping and dissection. Now, over five years since their first reports, percutaneous AVF is one of the most innovative and significant steps forward in native dialysis vascular access (VA) creation.
Objectives:
At the end of this course, participants should be able to:
• Describe the steps of the pAVF endovascular procedure
• Identify the criteria for patient selection
• Demonstrate the step-by-step duplex ultrasonography protocol used for the pre-operative vessel mapping and post-operative surveillance.
Additional Details Will Be Posted as Soon as Information is Available.